Difference between revisions of "Epidermal growth factor receptor inhibitors"
Jump to navigation
Jump to search
(+TKI) |
m |
||
Line 6: | Line 6: | ||
Note: | Note: | ||
*Both ''gefitinib'' and ''erlotinib'' are also classified as ''tyrosine kinase inhibitors'' ( | *Both ''gefitinib'' and ''erlotinib'' are also classified as ''[[tyrosine kinase inhibitors]]'' (TKIs). | ||
==Use== | ==Use== |